These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 34742270)

  • 1. POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trial.
    Zhao XR; Fang H; Tang Y; Hu ZH; Jing H; Liang L; Yan XN; Song YW; Jin J; Liu YP; Chen B; Tang Y; Qi SN; Li N; Lu NN; Men K; Hu C; Zhang YH; Li YX; Wang SL
    BMC Cancer; 2021 Nov; 21(1):1185. PubMed ID: 34742270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer: A Randomized Phase 3 Clinical Trial.
    Kim YB; Byun HK; Kim DY; Ahn SJ; Lee HS; Park W; Kim SS; Kim JH; Lee KC; Lee IJ; Kim WT; Shin HS; Kim K; Shin KH; Nam CM; Suh CO
    JAMA Oncol; 2022 Jan; 8(1):96-105. PubMed ID: 34695841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant medial versus entire supraclavicular lymph node irradiation in high-risk early breast cancer (SUCLANODE): a protocol for a multicenter, randomized, open-label, phase 3 trial.
    Zhang L; Mei X; Hu Z; Yu B; Zhang C; Li Y; Liu K; Ma X; Ma J; Chen X; Meng J; Shi W; Wang X; Mo M; Shao Z; Zhang Z; Yu X; Guo X; Yang Z
    BMC Cancer; 2024 Jan; 24(1):49. PubMed ID: 38195438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survival outcomes following internal mammary node irradiation in stage II-III breast cancer: results of a large retrospective study with 12-year follow-up.
    Chang JS; Park W; Kim YB; Lee IJ; Keum KC; Lee CG; Choi DH; Suh CO; Huh SJ
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):867-72. PubMed ID: 23747215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy.
    Hennequin C; Bossard N; Servagi-Vernat S; Maingon P; Dubois JB; Datchary J; Carrie C; Roullet B; Suchaud JP; Teissier E; Lucardi A; Gerard JP; Belot A; Iwaz J; Ecochard R; Romestaing P
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):860-6. PubMed ID: 23664327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.
    Henke G; Knauer M; Ribi K; Hayoz S; Gérard MA; Ruhstaller T; Zwahlen DR; Muenst S; Ackerknecht M; Hawle H; Fitzal F; Gnant M; Mátrai Z; Ballardini B; Gyr A; Kurzeder C; Weber WP
    Trials; 2018 Dec; 19(1):667. PubMed ID: 30514362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist?
    Freedman GM; Fowble BL; Nicolaou N; Sigurdson ER; Torosian MH; Boraas MC; Hoffman JP
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):805-14. PubMed ID: 10705000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Regional Nodal Irradiation for Breast Cancer Patients with Supraclavicular and/or Internal Mammary Lymph Node Involvement: A Multicenter, Retrospective Study (KROG 16-14).
    Kim K; Jeong Y; Shin KH; Kim JH; Ahn SD; Kim SS; Suh CO; Kim YB; Choi DH; Park W; Cha J; Chun M; Lee DS; Lee SY; Kim JH; Park HJ; Jung W
    Cancer Res Treat; 2019 Oct; 51(4):1500-1508. PubMed ID: 30913866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer.
    Qi WX; Cao L; Zheng S; Xu C; Cai R; Xu H; Cai G; Chen J
    BMC Cancer; 2022 Dec; 22(1):1356. PubMed ID: 36575421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Effectiveness of an Adaptive Treatment Planning Algorithm for Intensity Modulated Radiation Therapy Versus 3D Conformal Radiation Therapy for Node-Positive Breast Cancer Patients Undergoing Regional Nodal Irradiation/Postmastectomy Radiation Therapy.
    Bazan JG; Healy E; Beyer S; Kuhn K; DiCostanzo D; Smith TL; Jhawar S; White JR
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1159-1171. PubMed ID: 32711036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internal mammary node irradiation in node-positive breast cancer treated with mastectomy and taxane-based chemotherapy.
    Cho WK; Chang JS; Park SG; Kim N; Choi DH; Kim H; Kim YB; Park W; Suh CO
    Breast; 2021 Oct; 59():37-43. PubMed ID: 34126377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dummy run of quality assurance program in a phase 3 randomized trial investigating the role of internal mammary lymph node irradiation in breast cancer patients: Korean Radiation Oncology Group 08-06 study.
    Chung Y; Kim JW; Shin KH; Kim SS; Ahn SJ; Park W; Lee HS; Kim DW; Lee KC; Suh HS; Kim JH; Shin HS; Kim YB; Suh CO
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):419-26. PubMed ID: 25636764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
    Courdi A; Chamorey E; Ferrero JM; Hannoun-Lévi JM
    Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internal mammary node irradiation improves 8-year survival in breast cancer patients: results from a retrospective cohort study in real-world setting.
    Wang X; Luo J; Jin K; Chen X; Zhang L; Meng J; Zhang X; Zhang Z; Shao Z; Bazan JG; Guo X; Yang Z; Yu X
    Breast Cancer; 2020 Mar; 27(2):252-260. PubMed ID: 31696449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for the postoperative radiotherapy in N1 breast cancer patients (PORT-N1) trial, a prospective multicenter, randomized, controlled, non-inferiority trial of patients receiving breast-conserving surgery or mastectomy.
    Lee TH; Chang JH; Jang BS; Kim JS; Kim TH; Park W; Kim YB; Kim SS; Han W; Lee HB; Shin KH
    BMC Cancer; 2022 Nov; 22(1):1179. PubMed ID: 36384573
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Liu J; Tan Y; Bi Z; Huang S; Zhang N; Zhang AD; Zhao L; Wang Y; Liang Z; Hou Y; Xu X; Chen J; Wang F; Lan X; Lin X; Zhang X; Zhou W; Ye X; Guo JG; Wang X; Ding R; Chen J; Huang X
    BMJ Open; 2024 Jul; 14(7):e078049. PubMed ID: 39079921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer.
    Fowble B; Hanlon A; Freedman G; Nicolaou N; Hoffman J; Sigurdson E; Boraas M; Torosian M; Goldstein L
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):883-94. PubMed ID: 10863056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated radiotherapy with simultaneous tumor bed boost (Hi-RISE) in breast cancer patients receiving upfront breast-conserving surgery: study protocol for a phase III randomized controlled trial.
    Jin K; Luo J; Yu X; Guo X
    Radiat Oncol; 2024 May; 19(1):62. PubMed ID: 38802888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization patterns and temporal trends of internal mammary nodal irradiation at a tertiary cancer center.
    Misra S; Lee G; Maganti M; Koch CA
    Breast Cancer Res Treat; 2020 Jul; 182(2):367-379. PubMed ID: 32474745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard Tangential Radiation Fields Do Not Provide Incidental Coverage to the Internal Mammary Nodes.
    Loganadane G; Kassick M; Kann BH; Young MR; Knowlton CA; Evans SB; Higgins SA; Belkacemi Y; Potenziani M; Saltmarsh N; Wilson LD; Moran MS
    Pract Radiat Oncol; 2020; 10(1):21-28. PubMed ID: 31394256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.